Industry News

香港已成为全球第二大生物科技集资中心。 自港交所2018年修改《上市规则》引入18A章，允许生物科技公司来香港上市以来，截止至2020年12月31日，共有 28 家未盈利生物科技公司根据上市规则第18A章在香港交易所主板上市。 (more…)

Startup Sana Biotechnology could go public at a $10 billion valuation. Recent history suggests the high price tag may be worth it. PHOTO: WATCHARA PHOMICINDA/ZUMA PRESS A biotechnology startup is poised to go public with a roughly $10 billion price tag a year before it begins human clinical trials for its…

The 2021 American Cancer Society annual Cancer Statistics report found that the overall rate of cancer mortality continuously declined from 1991 to 2018 but also highlighted racial and geographic disparities. The 2021 American Cancer Society (ACS) annual Cancer Statistics report found that while the overall rate of cancer mortality continuously declined from…

Atalanta Therapeutics has broken cover with $110 million from a series A round and partnerships with Biogen and Genentech. The biotech secured the deals and funding on the strength of evidence it can durably silence genes in the brain. Research into the genetics of neurodegenerative diseases has pointed to new, better ways…

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes. Nine months. In March 2020, the United States was in the early stages of the COVID-19 pandemic. We shut the entire country down and ground the economy to a halt in an…

新冠肺炎疫情於全球各國帶來數以萬計的死亡個案，科學家們日以繼夜研究，期望找到應對病毒的方法。英國有醫學雜誌近日刊出臨床病例，指1名患嚴重腎病及淋巴癌六旬男子因呼吸困難入院，不幸確診新冠肺炎。不過4個月後，男子的斷層掃描報告竟顯示體內的腫瘤離奇消失，科研人員不排除情況因新冠病毒觸發人體抗腫瘤免疫反應所致，將循相關方向研究。 (more…)

Peking University team say their patented sensing chip is as accurate as the standard PCR testing, based on initial study results. They say the technology is ready for immediate use, but some think there could be challenges for mass production. It can take hours or days to get a result…

一直以来，当大脑需要药物治疗时，无论是因为阿尔茨海默病、脑肿瘤，还是因为脑部遭受外伤，要把药物分子送达所需的脑组织是项艰巨的挑战。给大脑送药的一道主要障碍是所谓的“血脑屏障”。新年伊始，根据《科学》子刊Science Advances的一篇研究论文，科学家们利用纳米颗粒为解决这一药物递送难题提供了一种富有潜力的新方法。 (more…)

A ribbon model of a protein. Credit: Emw/Wikimedia CC BY-SA 3.0 Proteins are essential to cells, carrying out complex tasks and catalyzing chemical reactions. Scientists and engineers have long sought to harness this power by designing artificial proteins that can perform new tasks, like treat disease, capture carbon or harvest energy,…

The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months.  After the many drug approvals, startup foundations, and venture capital highs we saw in 2019, it looked like 2020 was going…

CROP biotechnology has reduced pesticide use associated with environmental impact and has been proven to be beneficial for agricultural biodiversity, according to a United Kingdom-based agricultural economist and scientists from the University of the Philippines Los Baños (UPLB) during a recent online technical forum. In a recent online technical forum…

A flurry of healthcare IPOs in Hong Kong since a rule change in 2018 has been impressive. The Hong Kong market can add a biotech string to its bow as Asia's burgeoning tech sector increasingly is attracting interest from U.S. investors. So-called "cornerstone" investors from outside Asia have accounted for…

Biopharmaceutical companies rush for IPO on Science and Technology Innovation Board Recently, numerous biopharmaceutical companies such as Nanmo Biology, Jiachuang Biology, Maiwei Biology, Dana Biology, Sailun Biology have applied for IPO on the Sci-tech Innovation Board. The companies are involved in innovative drug development, innovative drug services, original and unique…

Efficiency and sustainability go hand-in-hand, with an added bonus: farmers improve crop yields arming has always involved risk. Risk of pestilence, water shortages or excess, and weather events are only a few of the conditions affecting successful crop growth. Applied nutrients and crop protectors help plants thrive but can result…

The Aedes albopictus, which can spread Zika, seen way too close. Photo: Kevin Frayer/Getty Images Biotech companies are partnering with the U.S. military to engineer a better mosquito repellent.Why it matters: More than 1 million people die each year from mosquito-borne diseases, and existing repellents are limited in their effectiveness. Using synthetic biology to…

Despite the success this year of a few European biotech companies in the COVID-19 disaster, overall EU corporate investment in a biotech and key computing technologies lags far behind that of their US competitors, according to a new report by the European Commission’s Joint Research Centre. Despite the success this…

An exciting new project launches this week that brings together Scotland’s most successful export industry and leading biotechnology innovators to find new sustainable solutions from whisky co-products.  The Whisky Project is led by the Industrial Biotechnology Innovation Centre (IBioIC), co-funded by Zero Waste Scotland, and with additional support from the Scotch…

US FDA gives green light to pigs genetically engineered to lack allergenic sugar The US Food and Drug Administration has approved the first genetically modified animal for both human food consumption and possible biomedical uses, the agency announced Dec. 14. The animals are a line of domestic pigs engineered to lack…

(Reuters) - The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry powder to direct money at biotech and pharma firms in 2021, research firm PitchBook said on Monday. There is mixed news heading into…

Survey highlights nuanced nature of public opinion. As new biotechnologies become a reality, scientists and governments are grappling with the ethical and regulatory implications. Now, an in-depth survey from the Pew Research Center in the US has provided insight into what the average Joe is thinking, too. The survey examined…

Possible COVID-19 infection built into Covaxin vaccine trial design; Bharat Biotech to perform interim analysis in due course. Vaccine maker Bharat Biotech’s Phase-3 clinical trial design for its candidate Covaxin expects 130 COVID-19 infections among trial participants, according to details shared by the company on the government’s clinical trial website.Thus instances such as Haryana Health…